Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Trustmark Corp. (TRMK)
NASDAQFinancialsBanks - RegionalSnapshot 2026-11-05
$44.73-1.97%
Close 2026-11-05 · 1-day change
NASDAQFinancialsBanks - RegionalSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
4.33 → 4.29 EPS · FY ending Dec 31, 2027 · 5 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 5 to 5; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for TRMK yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
EPS at or above $3.9 for FY26 | Profit per share beats estimates by 8%. | Intact | EPS falls below $3.9 in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
TRMK is a regional bank with a moderate-risk, value-oriented profile, rather than a high-growth story. Its long-term thesis is intact, with recent financial performance in the top half of its industry and company momentum improving, but earnings quality remains fragile.
The evidence describes TRMK as cheap versus peers, with valuation and business expectations broadly aligned. The expectations gap is modestly negative, suggesting limited room for a large positive surprise based on the current evidence.
Near term, recent results were in line, while loans and deposits grew year over year; loans slipped slightly from the prior quarter. Expense control remains mixed, as costs rose year over year despite management’s focus on discipline, and earnings quality is still fragile.
Over the next one to three years, the thesis depends partly on loan and deposit growth and whether expense discipline improves. Near term, rate cuts could weigh on Financials, while continued strength from sector bellwethers could support sector momentum; misses or weaker guidance from those peers could weaken that tailwind.
The multi-year view is intact, supported by stronger recent performance and a valuation described as cheap versus peers, but fragile earnings quality and interest-rate sensitivity remain meaningful constraints. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Trustmark grows revenue about 4% yearly and keeps costs stable near $132 million. |
| Intact |
| Noninterest expense rises materially above $132.2 million next year |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 3 supplied quarters. Management reported: “First Quarter Highlights • Loans held for investment (HFI) increased 1.5% linked-quarter and represented 88.3% of total deposits at March 31, 2026 • Credit quality remained stable, net charge-offs represented 0.04% of average loans • Deposits expanded to $15.7 billion while the cost of total deposits declined 9 basis points linked-quarter to 1.63% • Noninterest income increased 2.7% linked-quarter, reflecting in part growth in mortgage banking revenue • Noninterest expense was unchanged linked-quarter, reflecting on-going expense management priorities Duane A.” “In addition, we experienced continued growth in noninterest income while noninterest expense remained unchanged, reflecting our continued focus on expense management.” Delivery assessment Nov 5, 2026 |
Revenue growth at or above 4% annually | A primary condition in Trustmark Corp.'s published investment case. The stated target is >=4% YoY. | Intact | YoY revenue growth falls below 4% next year | Revenue growth: -0.74% FY2026-Q3; GAAP. Published target: >=4% YoY. Target period is not explicitly aligned with this observation. Nov 5, 2026-0.742428 percent · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Valuation remains reasonable with P/E near 12 | A supporting condition in Trustmark Corp.'s published investment case. The stated target is <=13 P/E. | Intact | P/E rises above 13 without earnings growth | P/E (TTM): 11.50x As of 2026-11-05; trailing twelve months. The target timing and basis require a separate assessment. Nov 5, 202611.4987 ratio · calculatedLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$4.10 → $4.29 · observed estimates
$0.89B → $0.90B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $4.10 | $891,033,330 | 6 / 3 |
| 2026-07-25 | $4.10 | $891,033,330 | 6 / 3 |
| 2026-07-26 | $4.10 | $887,280,000 | 5 / 3 |
| 2026-07-27 | $4.10 | $891,033,330 | 6 / 3 |
| 2026-07-28 | $4.10 | $891,033,330 | 6 / 3 |
| 2026-07-29 | $4.10 | $887,280,000 | 5 / 3 |
| 2026-07-30 | $4.10 | $891,033,330 | 6 / 3 |
| 2026-07-31 | $4.11 | $885,120,000 | 5 / 3 |
| 2026-08-01 | $4.11 | $885,120,000 | 5 / 3 |
| 2026-08-02 | $4.11 | $886,566,670 | 6 / 3 |
| 2026-08-03 | $4.11 | $886,566,670 | 6 / 3 |
| 2026-08-04 | $4.11 | $886,566,670 | 6 / 3 |
| 2026-08-05 | $4.11 | $886,650,000 | 6 / 4 |
| 2026-08-06 | $4.11 | $885,120,000 | 5 / 3 |
| 2026-08-08 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-08-09 | $4.11 | $886,650,000 | 6 / 4 |
| 2026-08-10 | $4.11 | $886,650,000 | 6 / 4 |
| 2026-08-12 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-08-13 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-08-14 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-08-15 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-08-16 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-08-17 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-08-18 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-08-19 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-08-20 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-08-21 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-08-22 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-08-23 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-08-24 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-08-25 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-08-26 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-08-27 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-08-28 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-08-29 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-08-30 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-08-31 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-09-01 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-09-02 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-09-03 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-09-04 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-09-05 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-09-06 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-09-07 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-09-08 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-09-09 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-09-10 | $4.11 | $885,360,000 | 5 / 3 |
| 2026-09-11 | $4.18 | $894,080,000 | 5 / 3 |
| 2026-09-12 | $4.22 | $897,780,000 | 5 / 3 |
| 2026-09-13 | $4.22 | $897,780,000 | 5 / 3 |
| 2026-09-14 | $4.22 | $897,780,000 | 5 / 3 |
| 2026-09-15 | $4.22 | $897,780,000 | 5 / 3 |
| 2026-09-16 | $4.25 | $897,780,000 | 5 / 3 |
| 2026-09-17 | $4.29 | $902,180,000 | 5 / 3 |
| 2026-09-18 | $4.29 | $902,180,000 | 5 / 3 |
| 2026-09-19 | $4.29 | $902,180,000 | 5 / 3 |
| 2026-09-20 | $4.29 | $902,180,000 | 5 / 3 |
| 2026-09-21 | $4.29 | $902,180,000 | 5 / 3 |
| 2026-09-22 | $4.29 | $902,180,000 | 5 / 3 |
| 2026-09-23 | $4.29 | $902,180,000 | 5 / 3 |
| 2026-09-24 | $4.29 | $902,180,000 | 5 / 3 |
| 2026-09-25 | $4.29 | $902,180,000 | 5 / 3 |
| 2026-09-26 | $4.29 | $902,180,000 | 5 / 3 |
| 2026-09-27 | $4.29 | $902,180,000 | 5 / 3 |
| 2026-09-28 | $4.29 | $902,180,000 | 5 / 3 |
| 2026-09-29 | $4.29 | $902,180,000 | 5 / 3 |
| 2026-09-30 | $4.29 | $902,180,000 | 5 / 3 |
| 2026-10-01 | $4.29 | $902,180,000 | 5 / 3 |
| 2026-10-02 | $4.29 | $902,180,000 | 5 / 3 |
| 2026-10-03 | $4.33 | $906,960,000 | 5 / 3 |
| 2026-10-04 | $4.33 | $906,960,000 | 5 / 3 |
| 2026-10-05 | $4.33 | $906,960,000 | 5 / 3 |
| 2026-10-06 | $4.33 | $906,960,000 | 5 / 3 |
| 2026-10-07 | $4.33 | $906,960,000 | 5 / 3 |
| 2026-10-08 | $4.33 | $906,960,000 | 5 / 3 |
| 2026-10-09 | $4.33 | $906,960,000 | 5 / 3 |
| 2026-10-10 | $4.33 | $906,960,000 | 5 / 3 |
| 2026-10-11 | $4.33 | $906,960,000 | 5 / 3 |
| 2026-10-12 | $4.33 | $906,960,000 | 5 / 3 |
| 2026-10-13 | $4.33 | $906,960,000 | 5 / 3 |
| 2026-10-14 | $4.33 | $906,960,000 | 5 / 3 |
| 2026-10-15 | $4.33 | $906,960,000 | 5 / 3 |
| 2026-10-16 | $4.33 | $906,960,000 | 5 / 3 |
| 2026-10-17 | $4.33 | $906,960,000 | 5 / 3 |
| 2026-10-18 | $4.33 | $906,960,000 | 5 / 3 |
| 2026-10-19 | $4.33 | $906,960,000 | 5 / 3 |
| 2026-10-20 | $4.33 | $906,960,000 | 5 / 3 |
| 2026-10-21 | $4.33 | $906,960,000 | 5 / 3 |
| 2026-10-22 | $4.33 | $906,960,000 | 5 / 3 |
| 2026-10-23 | $4.33 | $906,960,000 | 5 / 3 |
| 2026-10-24 | $4.33 | $906,960,000 | 5 / 3 |
| 2026-10-25 | $4.33 | $906,960,000 | 5 / 3 |
| 2026-10-26 | $4.33 | $906,960,000 | 5 / 3 |
| 2026-10-27 | $4.33 | $906,960,000 | 5 / 3 |
| 2026-10-28 | $4.33 | $906,960,000 | 5 / 3 |
| 2026-10-29 | $4.33 | $905,892,560 | 5 / 3 |
| 2026-10-30 | $4.29 | $898,822,680 | 5 / 3 |
| 2026-10-31 | $4.29 | $898,822,680 | 5 / 3 |
| 2026-11-01 | $4.29 | $898,822,680 | 5 / 3 |
| 2026-11-02 | $4.29 | $898,822,680 | 5 / 3 |
| 2026-11-03 | $4.29 | $898,822,680 | 5 / 4 |
| 2026-11-04 | $4.29 | $898,822,680 | 5 / 4 |
| 2026-11-05 | $4.29 | $898,822,680 | 5 / 4 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 5 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.